Six things to know:
1. Fourth-quarter revenue was $55.6 million, a 20 percent year-over-year-increase.
2. U.S. revenue grew 19 percent compared to the same time last year. Spinal implant revenue in the U.S. jumped 32 percent year over year with $27.3 million, and U.S. orthobiologics revenue grew 7 percent compared to the same time last year.
3. International revenue clocked in at $5.4 million, growing 26 percent.
4. Full-year revenue was $191.5 million, a 24 percent increase compared to 2020. U.S. revenue in 2021 increased 23 percent with $171.4 million.
5.SeaSpine’s 7D Surgical saw $6 million in sales revenue during 2021.
6. SeaSpine expects 2022 revenue to hit $226 million to $230 million, an 18 to 20 percent growth compared to 2021.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.